Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma - Top-Institutions - MDSpire

Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma

By
Yiming Zhao
Lixia Liu
Wei Qian
Jianjun Li
Liang Xia
June 17, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

First Affiliated Hospital of Anhui Medical University

Hefei, Anhui
Key Differentiators
- Hematology
#2

University Medical Center Göttingen

Göttingen, Lower Saxony
Key Differentiators
- Hematology
#3

University Hospital of Bern

Bern, Bern
Key Differentiators
- Hematology
#4

Stanford University

Stanford, California
Key Differentiators
- Hematology
#5

University Clinic of Rostock

Rostock, Mecklenburg-Vorpommern
Key Differentiators
- Hematology

Original Source(s)

Frontiers In Oncology

Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma

by Yiming Zhao, Lixia Liu, Wei Qian, Jianjun Li, Liang Xia
June 17, 2026

Related Content

Frontiers In Medicine

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

Frontiers In Medicine

Automated bone marrow cell classification using ensemble learning: performance, generalization, and clinical interpretability

Frontiers In Cardiovascular Medicine

Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis